Summary
Biotage AB (Biotage) is a Sweden based biotechnology company. It provides comprehensive solutions in the field of medicinal and analytical chemistry, process development and genetic analysis. The company is a global service provider of instruments, reagents and service to selected customer groups in the life sciences sector which caters to some of the biggest pharmaceutical and biotechnological companies and leading academic institutions. Biotage offers products through three product categories, namely, Medicinal Chemistry, Analytical Chemistry and Process Development. Its major products include microwave synthesis, resins and solid phase extraction (SPE), flash purification cartridges and systems, and reaction screening instruments. The company has wholly owned subsidiaries in Sweden, the UK, Germany, France, Switzerland, Italy, the US and Japan and offers its products across the world. Biotage is headquartered in Uppsala, Sweden.
The company focuses on rapid and cost-effective delivery of quality diagnostic products to a diverse group of customers. Biotage seeks to analyze the user needs thoroughly to obtain the best quality solution with the best possible user benefit.
Biotage AB Key Recent Developments
Jan 11, 2012: Biotage Is Subject To Extended Patent Litigation In US
Oct 26, 2011: Biotage Appoints Erika Söderberg Johnson As Its New CFO And Business Controller
May 09, 2011: Biotage Announces USPTO Rejects All Claims In US Patent 7,138,061
Apr 27, 2011: Biotage Reports Net Sales Of SEK107.2m In Q1 2011
Feb 10, 2011: Biotage Reports Net Sales Of SEK428.9m In 2010
This comprehensive SWOT profile of Biotage AB provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
Biotage AB (Biotage) is a Sweden based biotechnology company. It provides comprehensive solutions in the field of medicinal and analytical chemistry, process development and genetic analysis. The company is a global service provider of instruments, reagents and service to selected customer groups in the life sciences sector which caters to some of the biggest pharmaceutical and biotechnological companies and leading academic institutions. Biotage offers products through three product categories, namely, Medicinal Chemistry, Analytical Chemistry and Process Development. Its major products include microwave synthesis, resins and solid phase extraction (SPE), flash purification cartridges and systems, and reaction screening instruments. The company has wholly owned subsidiaries in Sweden, the UK, Germany, France, Switzerland, Italy, the US and Japan and offers its products across the world. Biotage is headquartered in Uppsala, Sweden.
The company focuses on rapid and cost-effective delivery of quality diagnostic products to a diverse group of customers. Biotage seeks to analyze the user needs thoroughly to obtain the best quality solution with the best possible user benefit.
Biotage AB Key Recent Developments
Jan 11, 2012: Biotage Is Subject To Extended Patent Litigation In US
Oct 26, 2011: Biotage Appoints Erika Söderberg Johnson As Its New CFO And Business Controller
May 09, 2011: Biotage Announces USPTO Rejects All Claims In US Patent 7,138,061
Apr 27, 2011: Biotage Reports Net Sales Of SEK107.2m In Q1 2011
Feb 10, 2011: Biotage Reports Net Sales Of SEK428.9m In 2010
This comprehensive SWOT profile of Biotage AB provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:
- Business description - A detailed description of the company’s operations and business divisions.
- Corporate strategy - Analyst’s summarization of the company’s business strategy.
- SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history - Progression of key events associated with the company.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Executive biographies - A brief summary of the executives’ employment history.
- Key operational heads - A list of personnel heading key departments/functions.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities - A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
SECTION 1 - ABOUT THE COMPANY
Biotage AB - Key Facts
Biotage AB - Key Employees
Biotage AB - Key Employee Biographies
Biotage AB - Major Products and Services
Biotage AB - History
Biotage AB - Company Statement
Biotage AB - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Biotage AB - Key Manufacturing Facilities
SECTION 2 – COMPANY ANALYSIS
Biotage AB - Business Description
Biotage AB - Corporate Strategy
Biotage AB - SWOT Analysis
SWOT Analysis - Overview
Biotage AB - Strengths
Strength - Strong Geographical Presence
Strength - Customer Focused Product Development
Strength - Strong Customer Base
Biotage AB - Weaknesses
Weakness - Patent Disputes
Weakness - Low Debt to Equity Ratio
Biotage AB - Opportunities
Opportunity - Expansion in New Markets
Opportunity - Strategic Agreements/Alliances
Opportunity - Growing Aged Population
Biotage AB - Threats
Threat - Competition and Technological Change
Threat - Stringent Governmental Regulations
Threat - Changing Diagnostic Market Conditions
Biotage AB - Key Competitors
SECTION 3 – COMPANY FINANCIAL RATIOS
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES
Biotage AB, Pharmaceuticals & Healthcare, Deals By Year, 2006 to YTD 2012
Biotage AB, Pharmaceuticals & Healthcare, Deals By Type, 2006 to YTD 2012
Biotage AB, Medical Equipment, Deals By Year, 2006 to YTD 2012
Biotage AB, Medical Equipment, Deals By Type, 2006 to YTD 2012
Biotage AB, Recent Deals Summary
SECTION 5 – COMPANY’S RECENT DEVELOPMENTS
Biotage AB, Recent Developments
11/01/2012: Biotage Is Subject To Extended Patent Litigation In US
26/10/2011: Biotage Appoints Erika S?derberg Johnson As Its New CFO And Business Controller
09/05/2011: Biotage Announces USPTO Rejects All Claims In US Patent 7,138,061
27/04/2011: Biotage Reports Net Sales Of SEK107.2m In Q1 2011
10/02/2011: Biotage Reports Net Sales Of SEK428.9m In 2010
SECTION 6 – APPENDIX
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
LIST OF TABLES
Biotage AB, Key Facts
Biotage AB, Key Employees
Biotage AB, Key Employee Biographies
Biotage AB, Major Products and Services
Biotage AB, History
Biotage AB, Subsidiaries
Biotage AB, Key Manufacturing Facilities
Biotage AB, Key Competitors
Biotage AB, Ratios based on current share price
Biotage AB, Annual Ratios
Biotage AB, Interim Ratios
Biotage AB, Pharmaceuticals & Healthcare, Deals By Year, 2006 to YTD 2012
Biotage AB, Pharmaceuticals & Healthcare, Deals By Type, 2006 to YTD 2012
Biotage AB, Medical Equipment, Deals By Year, 2006 to YTD 2012
Biotage AB, Medical Equipment, Deals By Type, 2006 to YTD 2012
Biotage AB, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
LIST OF FIGURES
Biotage AB, Performance Chart (2007 - 2011)
Biotage AB, Ratio Charts
Biotage AB, Pharmaceuticals & Healthcare, Deals By Year, 2006 to YTD 2012
Biotage AB, Pharmaceuticals & Healthcare, Deals by Type, 2006 to YTD 2012
Biotage AB, Medical Equipment, Deals By Year, 2006 to YTD 2012
Biotage AB, Medical Equipment, Deals by Type, 2006 to YTD 2012
Biotage AB - Key Facts
Biotage AB - Key Employees
Biotage AB - Key Employee Biographies
Biotage AB - Major Products and Services
Biotage AB - History
Biotage AB - Company Statement
Biotage AB - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Biotage AB - Key Manufacturing Facilities
SECTION 2 – COMPANY ANALYSIS
Biotage AB - Business Description
Biotage AB - Corporate Strategy
Biotage AB - SWOT Analysis
SWOT Analysis - Overview
Biotage AB - Strengths
Strength - Strong Geographical Presence
Strength - Customer Focused Product Development
Strength - Strong Customer Base
Biotage AB - Weaknesses
Weakness - Patent Disputes
Weakness - Low Debt to Equity Ratio
Biotage AB - Opportunities
Opportunity - Expansion in New Markets
Opportunity - Strategic Agreements/Alliances
Opportunity - Growing Aged Population
Biotage AB - Threats
Threat - Competition and Technological Change
Threat - Stringent Governmental Regulations
Threat - Changing Diagnostic Market Conditions
Biotage AB - Key Competitors
SECTION 3 – COMPANY FINANCIAL RATIOS
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES
Biotage AB, Pharmaceuticals & Healthcare, Deals By Year, 2006 to YTD 2012
Biotage AB, Pharmaceuticals & Healthcare, Deals By Type, 2006 to YTD 2012
Biotage AB, Medical Equipment, Deals By Year, 2006 to YTD 2012
Biotage AB, Medical Equipment, Deals By Type, 2006 to YTD 2012
Biotage AB, Recent Deals Summary
SECTION 5 – COMPANY’S RECENT DEVELOPMENTS
Biotage AB, Recent Developments
11/01/2012: Biotage Is Subject To Extended Patent Litigation In US
26/10/2011: Biotage Appoints Erika S?derberg Johnson As Its New CFO And Business Controller
09/05/2011: Biotage Announces USPTO Rejects All Claims In US Patent 7,138,061
27/04/2011: Biotage Reports Net Sales Of SEK107.2m In Q1 2011
10/02/2011: Biotage Reports Net Sales Of SEK428.9m In 2010
SECTION 6 – APPENDIX
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
LIST OF TABLES
Biotage AB, Key Facts
Biotage AB, Key Employees
Biotage AB, Key Employee Biographies
Biotage AB, Major Products and Services
Biotage AB, History
Biotage AB, Subsidiaries
Biotage AB, Key Manufacturing Facilities
Biotage AB, Key Competitors
Biotage AB, Ratios based on current share price
Biotage AB, Annual Ratios
Biotage AB, Interim Ratios
Biotage AB, Pharmaceuticals & Healthcare, Deals By Year, 2006 to YTD 2012
Biotage AB, Pharmaceuticals & Healthcare, Deals By Type, 2006 to YTD 2012
Biotage AB, Medical Equipment, Deals By Year, 2006 to YTD 2012
Biotage AB, Medical Equipment, Deals By Type, 2006 to YTD 2012
Biotage AB, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
LIST OF FIGURES
Biotage AB, Performance Chart (2007 - 2011)
Biotage AB, Ratio Charts
Biotage AB, Pharmaceuticals & Healthcare, Deals By Year, 2006 to YTD 2012
Biotage AB, Pharmaceuticals & Healthcare, Deals by Type, 2006 to YTD 2012
Biotage AB, Medical Equipment, Deals By Year, 2006 to YTD 2012
Biotage AB, Medical Equipment, Deals by Type, 2006 to YTD 2012
